Search alternatives:
ng decrease » a decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » a decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
50 ng » 50 mg (Expand Search), 10 ng (Expand Search), 5 ng (Expand Search)
1_ we » _ we (Expand Search)
Showing 1 - 20 results of 65,855 for search '(((( 50 ng decrease ) OR ( 1_ we decrease ))) OR ( 50 ((_ decrease) OR (nn decrease)) ))', query time: 0.72s Refine Results
  1. 1
    Detection of the Challenging mutations at 1% VAF and 50 ng DNA input.

    Detection of the Challenging mutations at 1% VAF and 50 ng DNA input. by Lizhi Yu (12476136)

    Published 2022
    Save to List
    Saved in:
  2. 2
    IC<sub>50</sub>s data of antimalarials against controls.

    IC<sub>50</sub>s data of antimalarials against controls. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 3
    Drugs IC<sub>50</sub>s data during the study period.

    Drugs IC<sub>50</sub>s data during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 4
    SNPs IC<sub>50</sub>s data at codon 876 during the study period.

    SNPs IC<sub>50</sub>s data at codon 876 during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 5
    Association of polymorphic IC<sub>50s</sub> versus wild<i>-</i>type at codon 876 in selected drugs tested.

    Association of polymorphic IC<sub>50s</sub> versus wild<i>-</i>type at codon 876 in selected drugs tested. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 6
    Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs.

    Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

    Published 2024
    Save to List
    Saved in:
  7. 7
    ROC curve and P-R curve (attack traffic proportion = 50%).

    ROC curve and P-R curve (attack traffic proportion = 50%). by Longyan Ran (18452261)

    Published 2024
    Save to List
    Saved in:
  8. 8
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 13
    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 14
    Decreased Incidence of Type 1 Diabetes in Young Finnish Children

    Decreased Incidence of Type 1 Diabetes in Young Finnish Children by Anna Parviainen (9343391)

    Published 2020
    “…</p> <p>CONCLUSIONS</p> <p>The incidence of type 1 diabetes decreased among young Finnish children between 2003 and 2018. …”
    Save to List
    Saved in:
  15. 15
    The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases.

    The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. by Orna Mizrahi-Man (42539)

    Published 2022
    “…<p>For cluster sizes ranging from 1 to 4, we show the fraction of predicted heterozygotes with underlying unexpected intensities and the fraction of heterozygotes that are set to “No Call.” …”
    Save to List
    Saved in:
  16. 16
    Number of samples per site during the study period.

    Number of samples per site during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 17
    Performance of selected antimalarials against field isolates during the study period.

    Performance of selected antimalarials against field isolates during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 18
    <i>Pfmrp1</i> gene SNPs data during the study period.

    <i>Pfmrp1</i> gene SNPs data during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 19
    Performance of selected drugs against field isolates during the study period.

    Performance of selected drugs against field isolates during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 20
    Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period.

    Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period. by Winnie Okore (14139712)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: